scholarly journals Short-Term Treatment with Cell Wall Degrading Enzymes Increases the Activity of the Inositol Phospholipid Kinases and the Vanadate-Sensitive ATPase of Carrot Cells

1990 ◽  
Vol 94 (4) ◽  
pp. 1820-1829 ◽  
Author(s):  
Qiuyun Chen ◽  
Wendy F. Boss
Keyword(s):  
Cell Wall ◽  
Term Treatment ◽  
Cell Wall Degrading Enzymes ◽  
Short Term ◽  
Short Term Treatment ◽  
Carrot Cells ◽  
Degrading Enzymes ◽  
Inositol Phospholipid

Distribution within the plant or compartmentation does not contribute substantially to the detoxification of excess boron in sunflower (Helianthus annuus)

1999 ◽  
Vol 26 (2) ◽  
pp. 95 ◽  
Author(s):  
Frank Dannel ◽  
Heidrun Pfeffer ◽  
Volker Römheld
Keyword(s):  
Cell Wall ◽  
Helianthus Annuus ◽  
Term Treatment ◽  
Substantial Contribution ◽  
Insoluble Residue ◽  
Tolerance Mechanism ◽  
Additional Experiment ◽  
Short Term ◽  
Short Term Treatment ◽  
Helianthus Annuus L

Distribution and compartmentation of boron as possible mechanisms for the notable tolerance of sunflower (Helianthus annuus L.) to excess B supply have been studied. Following a short- term treatment (6 h) with 1000 µМ B, the distribution of B between different shoot organs was preferentially directed to the readily transpiring ones. Thus, B distribution in sunflower plants seems to be mainly influenced by transpiration and does not act as a B tolerance mechanism in sunflower. As a second possible mechanism for B tolerance, the compartmentation of B between water insoluble residue (i.e. cell wall) and cell sap (i.e. symplasm) was determined. Additional binding of B in the cell wall in response to excess B supply for 6 h was very low in leaves and negligible in roots. Thus, a substantial contribution of the cell wall in detoxification of excess B can be ruled out. In an additional experiment with a B supply of 1 µМ (marginal) to 1000 µМ (moderately toxic), the compartmentation of B between the apoplasmic fluid and the cell sap was investigated. The B concentration in the apoplasmic fluid was always lower than that in the symplasm. Thus, B was not excluded from the symplasm, but accumulated within it. The apoplasmic fluid did not contribute substantially to the detoxification of excess B in the leaf.

scholarly journals KIDNEY INJURY MOLECULE-1 AS AN EARLY AMIKACIN-INDUCED NEPHROTOXICITY MARKER IN PATIENTS WITH SEPSIS HOSPITALIZED IN THE INTENSIVE CARE UNIT

2019 ◽  
pp. 277-279
Author(s):  
TRISNI UNTARI DEWI ◽  
INSTIATY . ◽  
RUDIANTO SEDONO ◽  
GESTINA ALISKA ◽  
MUHAMMAD KHIFZHON AZWAR ◽  
...  
Keyword(s):  
Intensive Care ◽  
Kidney Injury ◽  
Term Treatment ◽  
Short Term ◽  
Short Term Treatment ◽  
Safe Level ◽  
Study Results ◽  
Early Biomarker ◽  
Kidney Injury Molecule 1 ◽  
Trough Plasma

Objective: This study sought to determine the correlation between trough plasma amikacin concentrations and urinary normalized kidney injurymolecule-1 (KIM-1) concentrations as an early biomarker of nephrotoxicity in patients with sepsis who are hospitalized in an intensive care unit.Methods: In this pilot study, 12 patients with sepsis were treated with amikacin 1000 mg/day between May 2015 and September 2015. The correlationbetween trough plasma amikacin concentrations measured after the third dose and the elevation of urinary normalized KIM-1 concentrations afterthe third amikacin dose relative to the first/second dose was evaluated.Results: In total, three patients had trough plasma amikacin concentrations exceeding the safe level (>10 μg/ml). Furthermore, eight patientsdisplayed higher normalized KIM-1 concentrations after third dose than after the first/second dose; however, there was no correlation betweentrough amikacin concentrations and the elevation of urinary normalized KIM-1 concentrations (r=0.3, p=0.3).Conclusion: The study results illustrated that short-term treatment with an amikacin dose of 1000 mg/day was generally safe in patients with sepsis.

Instrumentation in Voice Assessment and Treatment

1997 ◽  
Vol 6 (4) ◽  
pp. 9-16 ◽  
Author(s):  
Alison Behrman ◽  
Robert F. Orlikoff
Keyword(s):  
Clinical Practice ◽  
Scientific Method ◽  
Term Treatment ◽  
Treatment Goals ◽  
Short Term ◽  
Short Term Treatment ◽  
Voice Assessment ◽  
Assessment And Treatment ◽  
Computer Based ◽  
The Voice

Sophisticated, computer-based instrumentation has become increasingly available to the voice clinician. Yet substantial questions remain regarding its clinical necessity and usefulness. A theoretical model based on the scientific method is developed as a framework that can be used to guide the clinician in the selection and application of instrumental measures. Using the process of hypothesis testing, instrumentation is presented as an integral component of clinical practice. The uses of instrumental measures, and their relevance to long- and short-term treatment goals, are addressed. Clinical examples are presented to illustrate the incorporation of instrumentation and the scientific method into assessment and treatment.

Sign in / Sign up

Export Citation Format

Share Document